Clinical assessment of collagen cross-linked N-telopeptides as a marker of bone metabolism in patients with primary hyperparathyroidism
- 1 August 1999
- journal article
- clinical trial
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 53 (7) , 329-333
- https://doi.org/10.1016/s0753-3322(00)88506-6
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidismJournal of Clinical Endocrinology & Metabolism, 1996
- Prediction of Bone Mass in Renal Hyperparathyroidism by Newly Developed Bone Metabolic Markers: Evaluation of Serum Levels of Carboxy‐Terminal Pyridinoline Cross‐Linked Telopeptide of Type I Collagen and Carboxy‐Terminal Propeptide of Type I ProcollagenWorld Journal of Surgery, 1996
- Increased bone mineral density after parathyroidectomy in primary hyperparathyroidismJournal of Clinical Endocrinology & Metabolism, 1995
- Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urineJournal of Bone and Mineral Research, 1994
- A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urineJournal of Bone and Mineral Research, 1992
- Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosisJournal of Clinical Endocrinology & Metabolism, 1992
- Serum bone Gla protein as an indicator of parathyroidectomy in patients with secondary hyperparathyroidismWorld Journal of Surgery, 1990
- New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.Journal of Clinical Investigation, 1980
- Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue.Proceedings of the National Academy of Sciences, 1975